Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
11 août 2022 16h05 HE
|
Agile Therapeutics, Inc.
Second Consecutive Quarter of Increase in Twirla Demand and Decrease in Company Operating Expenses Cash on Hand Expected to Fund Operations Through 2022 Company Announces Twirla® Product Supply...
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022
28 juil. 2022 08h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after...
Agile Therapeutics Updates Second Quarter 2022 Guidance
12 juil. 2022 08h05 HE
|
Agile Therapeutics, Inc.
Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses (OPEX) Expected to be Below Guided Range PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) --...
Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel
08 juil. 2022 08h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in a...
Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering
06 juil. 2022 17h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its...
Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering
01 juil. 2022 09h20 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its...
Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference
17 mai 2022 08h01 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief Executive Officer, will...
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
12 mai 2022 16h05 HE
|
Agile Therapeutics, Inc.
Twirla Experienced Another Quarter of Double-Digit Demand Growth in First Quarter 2022 Twirla Business Plan Progressing Company Anticipates Future 2022 Quarterly Operating Expenses to be Lower ...
Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation
05 mai 2022 17h01 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today publicly released the findings of its first year of post-marketing...
Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022
03 mai 2022 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2022 financial results after the...